How did managers cope in a volatile Q1?
Eye on large-cap pharma and biotech
Banks 'part of the solution'
Reviewing the last quarter's financial records
Perfect storm of cost saving and regulatory burden behind deals
Looking back at the past to predict the market of tomorrow
55 managers joined the list this year